FdaApplication

ANDA 212284

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMANKIND PHARMA LTD
application_typeANDA
approval_date2020-02-12

Products (2)

ProductActive ingredientStrengthDosage form
RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE;ORAL
RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE;ORAL

2 products